This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.
9th IPF Summit
148 148 people viewed this event.
The pulmonary fibrosis field is entering a pivotal moment. Boehringer Ingelheim’s positive Phase 3 trials for nerandomilast, poised to be the first new approval in over a decade, have injected long-awaited momentum into the space.
Time: 9:00 AM – 5:00 PM
Venue details: Hilton Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States
Prices: USD 2599.00 – USD 5097.00
Speakers: Toby Maher, Professor of Clinical Medicine and Director of Interstitial Lung Disease, University of Southern California, and more
Topics: pulmonary, ipf, pulmonaryfibrosis, lung, respiratorymedicine
Event Organizer: Hanson Wade